Results 161 to 170 of about 86,826 (247)

Continuous hemodiafiltration during chemotherapy for acute kidney injury in spontaneous tumor lysis syndrome due to high-grade B-cell lymphoma: a case report. [PDF]

CEN Case Rep
Kawamura N, Wada Y, Motohashi T, Okawa H, Kawamura S, Sakurabayashi S, Sano K, Takeuchi K, Naito S, Aoyama T, Takeuchi Y.   +10 more
europepmc   +1 more source

An exploratory evaluation of the frequency of perioperative changes in electrolyte, acid–base, creatinine, glucose, and lactate variables in dogs and cats undergoing cranial surgery for tumor resection

Veterinary Surgery, EarlyView.
Abstract Objective To explore the frequency and severity of abnormalities in perioperative point‐of‐care bloodwork in dogs and cats undergoing cranial surgery for tumor resection with particular emphasis on dyskalemia development. Study design Retrospective observational study. Animals A total of 61 dogs and 14 cats undergoing cranial surgery for tumor
Zoe E. Weiss, Vishal D. Murthy, Steven E. Epstein, Kate Hopper, Sabrina N. Hoehne   +4 more
wiley   +1 more source

WCN24-468 PEGLOTICASE FOR TUMOR LYSIS SYNDROME

Kidney International Reports
Sreedhar Mandayam, Ashley Rodriguez, Valda Page, Evelyn Acosta, Biruh Workeneh   +4 more
doaj   +1 more source

Clinical tumor lysis syndrome associated with elranatamab in relapsed multiple myeloma: a case report [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Milanesio M, Olmedo J, Caeiro G, Basquiera AL.   +3 more
europepmc   +1 more source

Role of RIPK1/RIPK3/MLKL signalling pathway in sepsis‐associated acute kidney injury

Experimental Physiology, EarlyView.
Abstract Sepsis‐associated acute kidney injury (SA‐AKI) is a common clinical syndrome in critically ill patients, and its high mortality rate is closely related to complex pathological mechanisms. Existing studies have shown that the pathophysiological process of SA‐AKI involves complex multi‐mechanism interactions, including an uncontrolled systemic ...
Huijun Yin, Jingyi Wang, Huirong Han
wiley   +1 more source

Extracorporeal Membrane Oxygenation in the Management of Tumor Lysis Syndrome in Children: A Review of Cases. [PDF]

J Clin Med
Aidynbek Z, Kakenov E, Mironova O, Ydyrysheva K, Li T, Sazonov V.   +5 more
europepmc   +1 more source

Patient‐Centric First‐in‐Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T‐Cell Engagers in Multiple Myeloma

Clinical Pharmacology &Therapeutics, Volume 120, Issue 3, Page 745-752, September 2026.
The minimal anticipated biological effect level (MABEL) approach to first‐in‐human (FIH) dose calculation can lead to long dose‐escalation periods before observing clinical activity. We used a novel ex vivo MABEL approach to calculate the FIH starting dose for forimtamig, a T‐cell bispecific antibody under investigation for the treatment of relapsed ...
Thomas E. Kraft, Estelle Marrer‐Berger, Sara Belli, Helene Haegel, Anneliese Schneider, Anna Maria Giusti, Michael Bscheider, Wolfgang Jacob, Martin Weisser, Laura Blanco, Nicolas Frances, Eva Rossmann, Guido Steiner, Aintzane Zabaleta Azpiroz, Bruno Paiva, Ludovic Martinet, Tanja Fauti   +16 more
wiley   +1 more source

Atypical Presentation of Tumor Lysis Syndrome Complicated by Rasburicase-Induced Methemoglobinemia. [PDF]

Cureus
Rahman M, Hussaini F.
europepmc   +1 more source

Defining a Therapeutic Window for Venetoclax in Post‐Transplant Maintenance Therapy for High‐Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Hematological Oncology, Volume 44, Issue 5, September 2026.
ABSTRACT Patients with high‐risk acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) continue to face a substantial risk of relapse after allogeneic hematopoietic stem cell transplantation (allo‐HSCT), which remains a leading cause of treatment failure.
Cuicui Lyu, Tianle Xie, Yedi Pu, Xianshuang Luan, Xia Xiao, Mingfeng Zhao, Hairong Lyu   +6 more
wiley   +1 more source

Spontaneous Tumor Lysis Syndrome in the Setting of Pancreatic Adenocarcinoma. [PDF]

Cureus
Coyne BM, Ishaq SM, Coyne CJ, Shiflett BS, Birnbaum JT.   +4 more
europepmc   +1 more source